ABIM

JUNE 30, 2025

DeVault, MD, Chair, ABIM Gastroenterology Board The Gastroenterology Board , which meets twice a year and is responsible for oversight of ABIM policy and assessment in the specialty, held its spring meeting on April 30, 2025. Sterling, MD , whose terms on the Specialty Board end June 30, 2025. Applications are due July 20, 2025.

Board-Certified 52

Board-Certified Government Community Internal Medicine 52

ABIM

JUNE 12, 2025

Ruiz, MD, Chair, ABIM Geriatric Medicine Board The Geriatric Medicine Board , which meets twice a year and is responsible for oversight of policy and assessment in the specialty, held its spring meeting on March 28, 2025. Ruiz, MD , whose three-year term as chair ends June 30, 2025. Community Practice in ABIM Governance* Erica N.

Board-Certified 52

Board-Certified Internal Medicine Government Community 52

ABIM

JUNE 11, 2025

Erin Bonura, MD, Chair, ABIM Infectious Disease Board The Infectious Disease Board , which meets twice a year and is responsible for oversight of ABIM policy and assessment in the specialty, held its spring meeting on March 25, 2025. JD , whose terms on the Specialty Board end June 30, 2025.

Board-Certified 52

Board-Certified Government Community Education 52

ABIM

JUNE 4, 2025

Christine Twining, MD, Chair, ABIM Endocrinology, Diabetes and Metabolism Board The Endocrinology, Diabetes and Metabolism Board , which meets twice a year and is responsible for oversight of policy and assessment in the specialty, held its spring meeting on April 1, 2025. Community Practice in ABIM Governance* Erica N.

Diabetes 52

Diabetes Board-Certified Telehealth Government 52

ABIM

JUNE 24, 2025

Gertz, MD, MACP, Chair, ABIM Hematology Board The Hematology Board , which meets twice a year and is responsible for oversight of ABIM policy and assessment in the specialty, held its spring meeting on May 2, 2025. Most (49.5%) are in single-specialty group practice or multi-specialty group practice (38%).

Board-Certified 40

Board-Certified Board-Certified Physicians Government Community 40

FDA Law

MARCH 6, 2025

Both guidance documents recommend data management practices for collecting data for use in developing, tuning, and testing an artificial intelligence model and making changes to said model. population due to differences in demographics, practice of medicine, or standard of care. The DCP may also define the sources of the data (e.g.,

Manufacturing 105

Manufacturing Management Clinical Practice Clinic 105